Last reviewed · How we verify
Calcium Glycerophosphate (calcium glycerylphosphate)
Calcium Glycerophosphate (generic name: calcium glycerylphosphate) is a calcium glycerylphosphate drug. It is currently FDA-approved for Cardiac arrest, Disorder of electrolytes, Hyperkalemia.
Calcium Glycerophosphate is a mineral supplement that has been studied in various clinical trials for its use in dental applications, including pits and fissure sealants and toothpaste. It is a small molecule that acts as an inhibitor of HMG-CoA reductase, a key enzyme in cholesterol synthesis.
At a glance
| Generic name | calcium glycerylphosphate |
|---|---|
| Drug class | calcium glycerylphosphate |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
- Cardiac arrest
- Disorder of electrolytes
- Hyperkalemia
- Hypermagnesemia
- Hypocalcemia
- Hypocalcemic tetany
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Calcium Glycerophosphate CI brief — competitive landscape report
- Calcium Glycerophosphate updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Calcium Glycerophosphate
What is Calcium Glycerophosphate?
What is Calcium Glycerophosphate used for?
What is the generic name of Calcium Glycerophosphate?
What drug class is Calcium Glycerophosphate in?
What development phase is Calcium Glycerophosphate in?
Related
- Drug class: All calcium glycerylphosphate drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Metabolic
- Indication: Drugs for Cardiac arrest
- Indication: Drugs for Disorder of electrolytes
- Indication: Drugs for Hyperkalemia
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing